
|Videos|November 15, 2020
AAO: Medication could reduce burden of steroid drops for patients
Author(s)OTE Staff Reports
Cynthia Matossian, MD, FACS, ABES, presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.
Advertisement
Cynthia Matossian, MD, FACES, ABES, of Matossian Eye Associates, presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.
The study examined early experiences among cataract surgeons with the use of the injectabcle ophthalmic anti-inflammatory medications.Cynthia Matossian, MD, FACS, ABES presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA requires NAION warning across the GLP-1 receptor agonist class
2
Longer anti-VEGF intervals in AMD, BRVO, and DME: 3 clinical cases
3
Tenpoint Therapeutics opens telehealth access to Yuvezzi for adults with presbyopia
4
The interplay between cardiac disease and the eye
5








